Current Pharmaceutical Design

Editor-in-Chief:

William A. Banks  
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
USA

Back

Become EABM
Become Reviewer

Abstract Ahead of Print

Antenatal Corticosteroids for Fetal Lung Maturity – Too Much of a Good Thing?

Volume:25
Lenka Hrabalkova, Tsukasa Takahashi, Matthew W. Kemp and Sarah J. Stock*

Expression profile of MicroRNA: An Emerging Hallmark of Cancer

Volume:25
Uzma Zaheer, Muhammed Faheem, Ishtiaq Qadri, Nargis Begum, Hadi M. Yassine, Asmaa A. Al Thani and Shilu Mathew*

Neural Networks in Generalized Epilepsy and Novel Antiepileptic Drugs

Volume:25
Felix-Martin Werner* and Rafael Coveñas

Women’s Beliefs about Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists?

Volume:25
Michael Ceulemans*, Angela Lupattelli , Hedvig Nordeng , Marina Odalovic, Michael Twigg and Veerle Foulon

Stimuli-responsive Drug Delivery Systems as an Emerging Platform for Treatment of Rheumatoid Arthritis

Volume:25
Xiao-Ling Xu, Kong-Jun Lu, Xiao-Qin Yao, Xiao-Ying Ying and Yong-Zhong Du*

Non-clinical Models to Determine Drug Passage into Human Breast Milk

Volume:25
Domenico Ventrella, Monica Forni, Maria Laura Bacci and Pieter Annaert*

Next Generation Medical Management of Postpartum Hemorrhage

Volume:25
Jaclyn M. Phillips, John N. van den Anker and Homa K. Ahmadzia*

Sildenafil for Antenatal Treatment of Congenital Diaphragmatic Hernia: from Bench to Bedside

Volume:25
Francesca M. Russo, Felix De Bie, Ryan Hodges, Alan Flake and Jan Deprest*

Mobile health applications for prenatal assessment and monitoring

Volume:25
Wilfried Gyselaers*, D Lanssens , H Perry and A Khalil

Clinical Pharmacokinetic Studies in Pregnant Women and the Relevance of Pharmacometric Tools

Volume:25
André Dallmann*, Paola Mian, Johannes Van den Anker and Karel Allegaert

Thrombolytic Therapy for Acute Ischemic Stroke: Past and Future

Volume:25
Keita Shibata, Terumasa Hashimoto, Takuro Miyazaki*, Akira Miyazaki and Koji Nobe

Retinal and Choroidal Changes after Anti Vascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration

Volume:25
Sang Woo Kim, Jong Eun Woo, Yo Sep Yoon, Seunghwan Lee, Je Moon Woo and Jung Kee Min*

Circulating Insulin-like Growth Factor-1 Levels in Patients with Rheumatoid Arthritis : A Meta-analysis

Volume:25
Yu-Lan Zhao, Jun Wu, Tian-Ping Zhang, Qian-Yao Cheng, Xue-Ping Wang, Ming-Ming Gu, Hai-Feng Pan and Dong-Qing Ye*

Transcriptional characteristics of activated macrophages

Volume:25
Victor Glanz, Veronika A. Myasoedova, Vasily Sukhorukov, Andrey Grechko, Dongwei Zhang, Elena B. Romaneneko, Varvara A. Orekhova and Alexander Orekhov*

Cellular stress and general pathological processes

Volume:25
Gusev E. Yu and N. V. Zotova*

Base excision DNA repair deficient cells: From disease models to genotoxicity sensors

Volume:25
Daria V. Kim, Alena V. Makarova, Regina R. Miftakhova and Dmitry O. Zharkov*

Therapeutic potential of pigment epithelium-derived factor in cancer

Volume:25
Sho-ichi Yamagishi*, Yoshinori Koga, Ami Sotokawauchi, Naoki Hashizume, Suguru Fukahori, Takanori Matsui and Minoru Yagi

An update on the association of protein kinases with cardiovascular diseases

Volume:25
Fakhra Amin, Aijaz Ahmad, Anna Feroz, Shariq Shaheen Khaqi, Mohd Shahnwaz Khan, Shams Tabrez*, Syed Kashif Zaidi, Wasem H. Abdulaal, Anas Shamsi, Wajihullah Khan and Bilqees Bano*

Treatments for iron deficiency (ID): Prospective organic iron fortification

Volume:25
Dan Wan, Qinghua Wu, Hengjia Ni, Gang Liu, Zheng Ruan* and Yulong Yin

Methodological Approaches To Evaluate Fetal Drug Exposure

Volume:25
Naïm Bouazza, Frantz Foissac, Déborah Hirt, Saïk Urien, Sihem Benaboud, Gabrielle Lui and Jean-Marc Treluyer*

The Role Of Genetic Polymorphism In The Formation Of Arterial Hypertension, Type 2 Diabetes And Their Comorbidity

Volume:25
Anna Shalimova*, G. Fadieienko, O. Kolesnikova, A. Isayeva, V. Zlatkina, V. Nemtsova, K. Prosolenko, V. Psarova, N. Kyrychenko and M. Kochuieva

IL-23 blockers: born to be first-line biologic agents in IBD?

Volume:25
Marjorie C Argollo, Mariangela Allocca, Federica Furfaro and Silvio Danese*

Therapeutic potential of curcumin in the treatment of glioblastoma multiforme

Volume:25
Seyed Hossein Shahcheraghi , Mahtab Zangui , Marzieh Lotfi , Majid Ghayour-Mobarhan, Ahmad Ghorbani , Hossein Zarei Jaliani , Hamid Reza Sadeghnia and Amirhossein Sahebkar *

Prunella vulgaris: A comprehensive review of chemical constituents, pharmacological effects and clinical applications

Volume:25
Su-Juan Wang, Xiao-He Wang, Yuan-Yuan Dai, Ming-Hua Ma, Khalid Rahman, Hua Nian* and Hong Zhang*

Are we ready to include prognostic factors in inflammatory bowel disease trials?

Volume:25
Christopher R Lindholm and Corey A Siegel*

Fatty acids and antioxidants in multiple sclerosis: Therapeutic role of GEMSP

Volume:25
P Ahumada-Pascual, Daniel García Gañán, Yasmina El Berdei Montero and Ana Velasco*

Cell-Based Therapy For Perianal Fistulising Crohn’s Disease

Volume:25
Paulo Gustavo Kotze*, Antonino Spinelli and Amy Lightner

Drug delivery systems for diabetes treatment Running title: Delivery systems for insulin

Volume:25
Bozidaraka L. Zaric, Milan Obradovic, Emina Sudar-Milovanovic, Jovan Nedeljkovic, Vesna Lazic and Esma R. Isenovic*

Extracellular vesicles as drug delivery systems –methods of production and potential therapeutic applications

Volume:25
Magdalena Surman, Anna Drożdż, Ewa Stępień and Małgorzata Przybyło*

Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors

Volume:25
Pabitra Narayan Samanta, Supratik Kar* and Jerzy Leszczynski*

Molecular basis of modulating adenosine receptors activities

Volume:25
Mohammed Nooraldeen Mahmod Al-Qattan* and Mohd Nizam Mordi*

Bioavailability enhancement of poorly soluble drugs: The holy grail in pharma industry

Volume:25
Mamunur Rashid, Mohd Yaseen Malik, Sandeep K. Singh, Swati Chaturvedi, Jiaur R Gayen and Muhammad Wahajuddin*